Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ACLY | P53396 | 15/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23446190 | 0.86 | MEN1 (0.48) | ALDH1A1KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL168114 | 0.85 | ALDH1A1 (0.52) | ALDH1A1ACLYKDM4EDUSP3MEN1 | |
| Citric Acid SCHEMBL8626231 | 0.85 | ALDH1A1 (0.52) | ALDH1A1ACLYKDM4EDUSP3MEN1 | |
| SCHEMBL431247 | 0.83 | ALDH1A1 (0.41) | ALDH1A1ACLYLMNA | |
| SCHEMBL17183043 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ACLYKDM4EDUSP3MEN1 | |
| SCHEMBL3984927 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ACLYKDM4EDUSP3MEN1 | |
| SCHEMBL23724033 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ACLYKDM4EDUSP3MEN1 | |
| Water SCHEMBL13269323 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ACLYKDM4EDUSP3MEN1 | |
| Citric Acid SCHEMBL431248 | 0.83 | ALDH1A1 (0.54) | ALDH1A1ACLY | |
| Citric Acid SCHEMBL425249 | 0.83 | ALDH1A1 (0.54) | ALDH1A1ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2705879-B1 | COMBINATION OF OILS FOR ANTIPERSPIRANT COMPOSITIONS WITH IMPROVED WHITE MARK PROTECTION | HENKEL AG & CO KGAA (DE) | 2017-06-07 | — | — | EP | disclosed |
| EP-2480192-B1 | NON-AEROSOL WATER-FREE ANTIPERSPIRANT IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | HENKEL AG & CO KGAA (DE) | 2016-01-13 | — | — | EP | disclosed |
| EP-2480193-B1 | NON-AEROSOL WATER-FREE ANTIPERSPIRANT IN WHICH ACTIVE SUBSTANCES ARE MORE READILY RELEASED | HENKEL AG & CO KGAA (DE) | 2015-08-19 | — | — | EP | disclosed |
| EP-2705879-A1 | COMBINATION OF OILS FOR ANTIPERSPIRANT COMPOSITIONS WITH IMPROVED WHITE MARK PROTECTION | Henkel AG&Co. KGAA (DE) | 2014-03-12 | — | — | EP | disclosed |
| US-20080293647-A1 | Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer | BIOXELL S.P.A. (IT) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293647-A1 | Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer | VDR, CYP24A1, CYP27B1 | ALDH1A1 683/4885ACLY 2537/4885KDM4E 2216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.